Vaidyane Ayurved Laboratories (NSE:MADHAVBAUG) EPS (Basic): ₹8.51 (TTM As of Mar. 2026)


NSE:MADHAVBAUG Vaidya Sane Ayurved Laboratories Ltd NSE:MADHAVBAUG
80 GF Score
Price ₹170.00
GF Value ₹188.07
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Vaidyane Ayurved Laboratories EPS (Basic)?

Vaidyane Ayurved Laboratories NSE:MADHAVBAUG -0.58% 80 EPS (Basic) is ₹8.51 as of Mar. 2026. GuruFocus rates NSE:MADHAVBAUG with a GF Score™ of 80/100 and a GF Value™ of ₹188.07 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Vaidyane Ayurved Laboratories's basic earnings per share (Basic EPS) for the six months ended in Mar. 2026 was ₹3.95. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹8.51.

Vaidyane Ayurved Laboratories's EPS (Diluted) for the six months ended in Mar. 2026 was ₹3.48. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹8.04.

Vaidyane Ayurved Laboratories's EPS without NRI for the six months ended in Mar. 2026 was ₹3.48. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was 8.04.

During the past 12 months, Vaidyane Ayurved Laboratories's average EPS without NRIGrowth Rate was 305.30% per year. During the past 3 years, the average EPS without NRI Growth Rate was -6.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 8 years, Vaidyane Ayurved Laboratories's highest 3-Year average EPS without NRI Growth Rate was 157.10% per year. The lowest was -6.80% per year. And the median was 3.80% per year.

Vaidyane Ayurved Laboratories  (NSE:MADHAVBAUG) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Vaidyane Ayurved Laboratories EPS (Basic) Related Terms

Vaidyane Ayurved Laboratories EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Vaidyane Ayurved Laboratories's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vaidyane Ayurved Laboratories EPS (Basic) Chart

Vaidyane Ayurved Laboratories Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
EPS (Basic)
Get a 7-Day Free Trial 8.00 4.60 2.02 6.78 8.51

Vaidyane Ayurved Laboratories Semi-Annual Data
Mar19 Mar20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.90 3.59 3.19 4.56 3.95
NSE:MADHAVBAUG
80GF Score
Vaidya Sane Ayurved Laboratories Ltd NSE:MADHAVBAUG
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vaidyane Ayurved Laboratories EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Vaidyane Ayurved Laboratories's Basic EPS for the fiscal year that ended in Mar. 2026 is calculated as

Basic EPS (A: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(89.866-0)/10.560
=8.51

Vaidyane Ayurved Laboratories's Basic EPS for the quarter that ended in Mar. 2026 is calculated as

Basic EPS (Q: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(41.552-0)/10.519
=3.95

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹8.51

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of ₹8.51 mean?
Vaidyane Ayurved Laboratories (NSE:MADHAVBAUG) has a EPS (Basic) of ₹8.51 as of Mar. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Vaidyane Ayurved Laboratories and its competitors.
Is Vaidyane Ayurved Laboratories' EPS (Basic) too high?
Vaidyane Ayurved Laboratories' current EPS (Basic) is ₹8.51. Overall, Vaidyane Ayurved Laboratories has a GF Score™ of 80/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Vaidyane Ayurved Laboratories' EPS (Basic) compare to ZTS?
Vaidyane Ayurved Laboratories' EPS (Basic) of ₹8.51 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Drug Manufacturers company?
A good EPS (Basic) depends on the Drug Manufacturers industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Vaidyane Ayurved Laboratories and its competitors. Vaidyane Ayurved Laboratories's current EPS (Basic) is ₹8.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vaidyane Ayurved Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Vaidyane Ayurved Laboratories (NSE:MADHAVBAUG) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹188.07, compared to a current price of ₹170.00 — trading 9.6% below its estimated fair value. The current EPS (Basic) is ₹8.51. Vaidyane Ayurved Laboratories' overall GF Score™ is 80/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Vaidyane Ayurved Laboratories (NSE:MADHAVBAUG), the current EPS (Basic) is ₹8.51 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vaidyane Ayurved Laboratories (NSE:MADHAVBAUG) Overvalued in 2026?

Based on GuruFocus' analysis, Vaidyane Ayurved Laboratories stock appears to be undervalued. The current stock price of ₹170.00 is trading 9.6% below its estimated GF Value™ of ₹188.07. GuruFocus considers Vaidyane Ayurved Laboratories to be Modestly Undervalued.

Key valuation signals for NSE:MADHAVBAUG:

  • EPS (Basic): ₹8.51
  • GF Value™: ₹188.07 vs. price of ₹170.00 (9.6% below fair value)
  • GF Score™: 80/100 with 4 warning signs

No single metric tells the full story. See the NSE:MADHAVBAUG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Vaidyane Ayurved Laboratories Business Description

Address 201B, Bhoomi Velocity, Above ICICI Bank, Road No. 23, Wagle Estate, Thane (West), Thane, MH, IND, 400604
Vaidya Sane Ayurved Laboratories Ltd is a medical service institution. The company engaged in research and development in Ayurvedic Medicines and the sale of Ayurvedic medicines & products through its various franchises and own clinics. The Company is also engaged in providing Ayurved medical professional services across its various clinics, including panchkarma and other Ayurvedic treatments through the running of an Ayurvedic Hospital. The company mainly offers treatment for health disease reversal, diabetes reversal, BP management, obesity management, and knee pain relief. The company's business is divided into three segments, i.e., Hospital Activity, Sale of Product, and Common. It derives maximum revenue from the sale of Products.
80GF Score

Get the complete analysis for NSE:MADHAVBAUG

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹170.00
Price
₹188.07
GF Value